ONEVITE- ascorbic acid, cholecalciferol, thiamine hydrochloride, riboflavin, niacinamide, pyridoxine, folic acid, cyanocobalamin, biotin, calcium pantothenate, vitamin a acetate, vanadyl sulfate, .alpha.-lipoic acid and lutein tablet
Each Tablet Contains:
Other Ingredients: Di calcium phosphate, microcrystalline cellulose, croscarmellose sodium, stearic acid, silicon dioxide, titanium dioxide, PEG 8000, magnesium stearate, talc, HPMC E15 & HPMC E5/E6
INDICATIONS AND USAGE
ONEvite Tablets is an orally administered prescription vitamin supplement specifically formulated for the clinical dietary management of patients with unique nutritional needs requiring, increased folate levels and nutritional supplementation in physiologically stressful conditions. As well as for maintenance of good health and beneficial in maintaining overall skin health, also help maintain healthy blood sugar levels and help promote nerve health and function including normal vision.
ONEvite Tablets is contraindicated in patients with hypersensitivity to any of its components. Folic Acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.
Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (Vitamin B12).
Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur.
Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive.
The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency.
Avoid Over dosage. Keep out of the reach of children.
High doses of folic acid may result in decreased serum levels of anticonvulsant drugs.
Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.
Consult appropriate references for additional specific vitamin-drug interactions.
Information for Patients
Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breastfeeding.
Not recommended for pediatric use.
Adverse reactions have been reported with specific vitamins and minerals, but generally at levels substantially higher than those in ONEvite T ablets
DOSAGE AND ADMINISTRATION
ONEvite Tablets is a white film coating with caplet shape.
One tablet daily or as directed by a physician.
ONEvite Tablets available 90 tablets per bottle,
Store at room temperature 15°-30°C (59°-86°F). Avoid excessive heat and moisture.
To report a serious adverse event or obtain product information, call 631-524-5758
Brentwood, NY 11717
MADE IN USA
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
| ONEVITE |
|Labeler — NEOMED PHARMACEUTICAL (048388130)|
Revised: 06/2019 NEOMED PHARMACEUTICAL
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.